Concepedia

Lopinavir/ritonavir treatment in HIV antiretroviral‐experienced patients: evaluation of risk factors for liver enzyme elevation

Paola Meraviglia, Monica Schiavini, Antonella Castagna, Paola Viganò, Teresa Bini, Simona Landonio, Anna Danise, MC Moioli, Elena Angeli, Marco Bongiovanni,

HIV Medicine · 2004 · 61 citations · 20 references

DOI

Abstract

HCV and HBV testing and measurement of baseline ALT values are essential for screening subjects at risk of LEE before starting LPV/r. Strict monitoring of clinical and biochemical parameters should be performed in these patients.

References

20

Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus Infection

Mark Sulkowski · JAMA · 2000 · 957 citations

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections

Mark Sulkowski, David L. Thomas, Shruti H. Mehta et al. · Hepatology · 2002 · 521 citations

, , +21

Factors Affecting Liver Fibrosis in Human Immunodeficiency Virus-And Hepatitis C Virus-Coinfected Patients: Impact of Protease Inhibitor Therapy

Yves Benhamou, Vincent Di Martino, Marie Bochet et al. · Hepatology · 2001 · 428 citations · Full text

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

Marieke den Brinker, Ferdinand W.N.M. Wit, Pauline M. E. Wertheim-van Dillen et al. · AIDS · 2000 · 396 citations

Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy

Estebán Martínez, José Luís Blanco, Juan A. Arnaiz et al. · AIDS · 2001 · 351 citations